Sigrid Lundgren

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Placebo Controlled

Pulmonary Artery

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Sigrid Lundgren, Karl Wallblom, Jane Fisher, Susanne Erdmann, Artur Schmidtchen, Karim Saleh
Study protocol for a phase 1, randomised, double-blind, placebo-controlled study to investigate the safety, tolerability and pharmacokinetics of ascending topical doses of TCP-25 applied to epidermal suction blister wounds in healthy male and female volunteers. BMJ open 13 (2) (2023)
Sigrid Lundgren, Karl Wallblom, Jane Fisher, Susanne Erdmann, Artur Schmidtchen, Karim Saleh
Study protocol for a phase 1, randomised, double-blind, placebo-controlled study to investigate the safety, tolerability and pharmacokinetics of ascending topical doses of TCP-25 applied to epidermal suction blister wounds in healthy male and female volunteers. BMJ open 13 (2) (2023)
Sigrid Lundgren, Karl Wallblom, Jane Fisher, Susanne Erdmann, Artur Schmidtchen, Karim Saleh
Study protocol for a phase 1, randomised, double-blind, placebo-controlled study to investigate the safety, tolerability and pharmacokinetics of ascending topical doses of TCP-25 applied to epidermal suction blister wounds in healthy male and female volunteers. BMJ open 13 (2) (2023)
Sigrid Lundgren, Karl Wallblom, Jane Fisher, Susanne Erdmann, Artur Schmidtchen, Karim Saleh
Study protocol for a phase 1, randomised, double-blind, placebo-controlled study to investigate the safety, tolerability and pharmacokinetics of ascending topical doses of TCP-25 applied to epidermal suction blister wounds in healthy male and female volunteers. BMJ open 13 (2) (2023)
Sigrid Lundgren, Karl Wallblom, Jane Fisher, Susanne Erdmann, Artur Schmidtchen, Karim Saleh
Study protocol for a phase 1, randomised, double-blind, placebo-controlled study to investigate the safety, tolerability and pharmacokinetics of ascending topical doses of TCP-25 applied to epidermal suction blister wounds in healthy male and female volunteers. BMJ open 13 (2) (2023)
Sigrid Lundgren, Karl Wallblom, Jane Fisher, Susanne Erdmann, Artur Schmidtchen, Karim Saleh
Study protocol for a phase 1, randomised, double-blind, placebo-controlled study to investigate the safety, tolerability and pharmacokinetics of ascending topical doses of TCP-25 applied to epidermal suction blister wounds in healthy male and female volunteers. BMJ open 13 (2) (2023)